39 results
Thumbnail

D1.58 - Pilocarpine in the management of allergic rhinosinusitis; a prospective, placebo-controlled study for a novel use of a cholinergic agent

Thumbnail

D1.68 - Rice allergy: a case report

Thumbnail

D1.59 - Asymptomatic sensitisation to food allergens is common in adults -findings from the PAFA study

Thumbnail

D1.60 - Impact of real-world confounders on the accuracy of an AI model to support the read out of skin prick automated test results

Thumbnail

D1.62 - Improved In-vitro Allergy Diagnostics using a Molecular Composite of Purified Peanut Allergens

Thumbnail

D1.63 - Descriptive Study on the Evolution of Patients Treated with Oral Immunotherapy (OIT) Using Pasteurized Egg White at the Fundación Alcorcón University Hospital

Thumbnail

D1.64 - Severe Food Protein-Induced Enterocolitis Syndrome: A French Multicenter Study of Children Admitted to Critical Care

Thumbnail

D1.65 - Pollen Food Allergy Syndrome in Patients with Quercus ilex Sensitization in the Population of Madrid

Thumbnail

D1.66 - Reactivity, severity and tolerance development in 50 wheat-allergic children across two oral food challenges

Thumbnail

D1.67 - Development and validation of Skin Prick Test solutions for assessing sensitization patterns to edible insects among children sensitized to house dust mite

Thumbnail

D1.69 - Safety in the peach juice food challenge in LTP allergic patients

Thumbnail

D1.70 - No more restrictive diets for LTP allergic patients. The importance of oral food challenge

Thumbnail

D1.71 - Risk Factors for Anaphylaxis in Food-Allergic Children During Oral Food Challenge Tests

Thumbnail

D1.72 - Comparison of the allergenic composition of available SPTs for the diagnosis of sensitization to D. pteronyssinus

Thumbnail

D1.57 - Antigen-specific IgE antibody levels as negative predictors of oral food challenge with cow's milk in children with cow's milk allergy

Thumbnail

D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab

Thumbnail

D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab

Thumbnail

D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis

Thumbnail

D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic

Thumbnail

D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates